Novel Pt(IV) prodrug self-assembled nanoparticles with enhanced blood circulation stability and improved antitumor capacity of oxaliplatin for cancer therapy
AbstractPt(IV) compounds are regarded as prodrugs of active Pt(II) drugs (i.e. cisplatin, carboplatin, and oxaliplatin) and burgeoned as the most ideal candidates to substitute Pt(II) anticancer drugs with severe side effects. Nanoparticle drug delivery systems have been widely introduced to deliver...
Saved in:
Main Authors: | Yuanlei Fu (Author), Ying Kong (Author), Xiangping Li (Author), Dongfang Cheng (Author), Yuqian Hou (Author), Yan Li (Author), Tongfang Li (Author), Yani Xiao (Author), Qiuyan Zhang (Author), Rong Rong (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin in vivo and in vitro
by: Tingting Lang, et al.
Published: (2021) -
Enhanced stability and efficacy of GEM-TOS prodrug by co-assembly with antimetastatic shell LMWH-TOS
by: Rong Guo, et al.
Published: (2020) -
Berberine-based self-assembly agents with enhanced synergistic antitumor efficacy
by: Yun Wang, et al.
Published: (2024) -
Combination therapy to overcome ferroptosis resistance by biomimetic self-assembly nano-prodrug
by: Yong Huang, et al.
Published: (2023) -
Oxaliplatin-Biomimetic Magnetic Nanoparticle Assemblies for Colon Cancer-Targeted Chemotherapy: An In Vitro Study
by: Ylenia Jabalera, et al.
Published: (2019)